Astrana Health, Inc.
ASTH
$29.34
$0.1450.50%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 71.26% | -60.67% | |||
| Total Other Revenue | -1.79% | 21.08% | |||
| Total Revenue | -1.55% | 20.26% | |||
| Cost of Revenue | -1.84% | 24.94% | |||
| Gross Profit | 0.04% | -0.67% | |||
| SG&A Expenses | 5.15% | -7.15% | |||
| Depreciation & Amortization | -2.38% | 46.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.30% | 21.91% | |||
| Operating Income | -5.46% | -0.24% | |||
| Income Before Tax | -15.94% | 32.88% | |||
| Income Tax Expenses | -21.93% | 40.45% | |||
| Earnings from Continuing Operations | -13.19% | 29.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -7.12% | -32.96% | |||
| Net Income | -16.05% | 29.23% | |||
| EBIT | -5.46% | -0.24% | |||
| EBITDA | -4.85% | 6.45% | |||
| EPS Basic | -16.17% | 28.26% | |||
| Normalized Basic EPS | -25.43% | 39.88% | |||
| EPS Diluted | -17.50% | 29.03% | |||
| Normalized Diluted EPS | -25.71% | 40.10% | |||
| Average Basic Shares Outstanding | 0.15% | 0.75% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
